GlassScriptPhysician profile
Brendan Langford
NPI 1932604477
$4,463.60
in general payments reported to CMS, 2019-2025
14 companies · $831 in 2025
The $831 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.96 · 2021: $134 · 2022: $596 · 2023: $1,295 · 2024: $1,568 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,978 · Travel and Lodging: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,977.56 |
| Travel and Lodging | $717.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,136.25 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Nevro Corp. | $933.32 | 2023-2024 | Senza |
| Medtronic, INC. | $913.52 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Vectris Surescan |
| Abbott Laboratories | $417.82 | 2023-2025 | Eterna, Proclaim |
| Spr Therapeutics, INC | $367.87 | 2022-2023 | Sprint Pns System |
| Stryker Corporation | $183.39 | 2023-2025 | Mild Device Kit, Spinejack |
| Grt US Holding, INC. | $133.55 | 2021 | |
| Averitas Pharma INC. | $124.98 | 2023 | Qutenza |
| Nalu Medical, INC. | $86.81 | 2023 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $66.83 | 2023 | Mild Device Kit |
| Medtronic USA, INC. | $38.96 | 2019 | |
| Globus Medical, INC. | $21.31 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.21 | 2025 | Relistor |
| Spinal Simplicity, LLC | $18.78 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendan Langford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.